PHA 408(503555-55-3)
- Name: PHA 408
- Synonyms:PHA-408;
- Molecular Formula:C29H27ClFN7O2
- Molecular Weight:560.02
- CAS Registry Number:503555-55-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.503555-55-3 PHA 408
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.503555-55-3 PHA 408
Assay:99% Application:Fine chemical intermediates, used as the main raw material for zinc oxihe synthesis of various pesticides, medicines, surfactants, polymer monomers, nnd nntifungal agents
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.503555-55-3 PHA 408
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.503555-55-3 PHA 408
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:PHA 408
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.503555-55-3 PHA 408
Assay:99% Appearance:liquid or powder Package:according to the clients requirement Storage:Dry and Cool Place Transportation:UPS FedEx ,DHL,EXPRESS LINE Application:API
Min. Order:1Gram
Supplier:Shandong Mopai Biotechnology Co., LTD [
China (Mainland)] CAS No.503555-55-3 PHA 408
Assay:99% Package:inquiry Transportation:inquiry Application:PHA 408 is a selective and ATP-competitive IKB kinase-2 (IKK-2) inhibitor (IC50 = 40 nM), which binds IKK-2 tightly with a relatively slow off rate.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 872002-72-7/Quinoxaline, 6-[[4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]-
- 884339-27-9/N-[4-[(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-N'-[2-methoxy-5-(trifluoromethyl)phenyl]-
- 917369-31-4/N-(4-Methoxyphenyl)-N,2-dimethyl-4-quinazolinamine hydrochloride
- 1144161-05-6/Benzamide, N-[1,2-dihydro-2-(4-methoxyphenyl)-1-oxopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl]-
- 1052112-65-8/2-Propyn-1-ol, 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-, 2,2,2-trifluoroacetate (1:2)
- 842148-40-7/AKT Kinase Inhibitor
- 66774-80-9/Inhoffen Lythgoe Diol Monotosylate
- 141404-08-2/Cyclohexanone, 3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-4-hydroxy-, (3R, 5R)
- 66774-71-8/Benzoic acid 7a-methyl-1-(1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester
- 886859-14-9/2-Thiophenecarboxamide, 3-[(1R)-1-[2-(difluoromethoxy)-4-[[(1,1-dimethylethyl)amino]methyl]phenyl]ethoxy]-5-imidazo[1,2-a]pyridin-3-yl-
- 321688-88-4/2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime]
- 1239513-63-3/Poloxipan
- 866772-52-3/Benzeneacetamide, α-(cyclopentylmethyl)-N-(5-methoxythiazolo[5,4-b]pyridin-2-yl)-4-[(4-methyl-1-piperazinyl)sulfonyl]-, (αR)-
- 258870-13-2/Butanediamide, N1-[(3S)-hexahydro-2-oxo-1-[(3-phenoxyphenyl)methyl]-1H-azepin-3-yl]-N4-hydroxy-2-(2-methylpropyl)-3-propyl-, (2R,3S)-
- 1191385-19-9/1,5-IsoquinolinediaMine, N1-(4-chlorophenyl)-6-Methyl-N5-[3-(9H-purin-6-yl)-2-pyridinyl]-, (Hydrochloride) (1:2)
- 896720-20-0/1H-Pyrrole-2-carboxamide, 4-[2-[(2-chloro-4-fluorophenyl)amino]-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-
- 931706-15-9/PPQ-102
- 503555-55-3/PHA 408
- 1195985-43-3/1H-Pyrazole-3-methanamine, 1-(4-bromophenyl)-N-[(1R)-1-(3-chlorophenyl)ethyl]-5-methoxy-α-methyl-, (αR)-
- 1192845-62-7/Benzenepropanoic acid, 3-cyano-4-[(2R)-3-[[1,1-diMethyl-2-(2-naphthalenyl)ethyl]aMino]-2-hydroxypropoxy]-, ethyl ester, (Hydrochloride) (1:1)
- 1192845-63-8/Benzenepropanoic acid, 3-cyano-4-[(2R)-3-[[1,1-diMethyl-2-(2-naphthalenyl)ethyl]aMino]-2-hydroxypropoxy]-, (Hydrochloride) (1:1)
- 300690-71-5/Moclobemide
- 911290-35-2/NW-1772
- 1248541-99-2/1H-Benzimidazole-7-carboxamide, 2-[1,1'-biphenyl]-4-yl-
- 1196059-50-3/1H-Benzimidazole-7-carboxamide, 2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-, 2,2,2-trifluoroacetate (20:19)
- 1197932-49-2/3-Isoxazolecarboxylic acid, 5-[(1E)-2-(4-quinolinyl)ethenyl]-, ethyl ester
- 1151513-25-5/1,2,4-Oxadiazole-3-methanamine, 5-[2-(phenylmethyl)-2H-indazol-3-yl]-
- 353504-54-8/1,2,4-Oxadiazole-3-methanamine, 5-[1-(phenylmethyl)-1H-indazol-3-yl]-
- 854755-48-9/A 790742
- 854758-17-1/A 792611